Low impact
Abbott Labs reported Q2 2026 adjusted EPS of $1.31 above estimates, raised its full-year adjusted EPS guidance to $5.45-$5.60, and posted organic sales growth of 4.8% with net sales of $12.59B.
FirstSquawk07/16, 06:33 PM
- Adj EPS $1.31 (est $1.276)
- FY Adj EPS Sees $5.45 To $5.60, Saw $5.38 To $5.58
- Comp Sales +4.8%
- Net Sales $12.59B (est $12.54B)
Figures as quoted by FirstSquawk
Related assets
Coming up for ABT
Explore next
Latest ABT news
Bloomberg08/21, 04:57 PM
FirstSquawk08/21, 06:28 AM
FirstSquawk08/21, 06:28 AM